Protagenic Therapeutics (PTIX) — Free Cash Flow Generation Index
Protagenic Therapeutics (PTIX) has a Free Cash Flow Generation Index of 1.00x as of December 2010. Free cash flow of $1.72 Million represents 1% of operating cash flow ($1.72 Million). See Protagenic Therapeutics (PTIX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Protagenic Therapeutics Free Cash Flow Generation Index (1999–2008)
Historical FCF Generation Index trend for Protagenic Therapeutics across 7 annual periods. Explore PTIX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Protagenic Therapeutics (1999–2008)
Year-by-year Free Cash Flow Generation Index for Protagenic Therapeutics. For the full company profile including market capitalisation, see PTIX market cap overview.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2008 | 0.53x | $2.33 Million | $4.36 Million | $2.03 Million | ▼ -41.8% |
| 2006 | 0.92x | $854.00K | $931.00K | $77.00K | ▲ +339.8% |
| 2003 | 0.21x | $390.00K | $1.87 Million | $1.48 Million | ▼ -13.1% |
| 2002 | 0.24x | $563.00K | $2.35 Million | $1.78 Million | ▲ +115.8% |
| 2001 | -1.52x | $-2.29 Million | $1.50 Million | $3.79 Million | ▼ -2017.1% |
| 2000 | 0.08x | $278.00K | $3.51 Million | $3.23 Million | ▼ -89.5% |
| 1999 | 0.76x | $250.00K | $331.00K | $81.00K | — |